Company Overview
Management Team
Board of Directors
Advisory Board
Investors
Product Overview
Intellectual Property
Publications
About Us
Products
Clinical Trials
Business Development
News
Contact Us
CT-011
Others
Company Overview
Management Team
Board of Directors
Advisory Board
Investors
Product Overview
Intellectual Property
Publications
About Us
Products
Clinical Trials
Business Development
News
Contact Us
CT-011
>
Overview
>
Intellectual Property
>
Scientific Publications
>
Contact Us
News
Teva will invest up to additional $10.5 Million in CureTech.
CureTech announces receipt of a Notice of Allowance from the US Patent and Trademark Office
Teva Pharmaceuticals To Invest $6 Million In CureTech
READ MORE >
> How does CT-011 work